Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.

CEO

Dr. Hans-Georg Feldmeier

Employees

3610

Country

Germany

ISIN

DE000A2GS5D8

Listings

0 Comments

Share your thoughts

FAQ

What is Dermapharm stock price today?▼

The current price of 0A5J.LSE is €45.6 EUR — it has increased by +0% in the past 24 hours. Watch Dermapharm stock price performance more closely on the chart.

What is Dermapharm stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Dermapharm stocks are traded under the ticker 0A5J.LSE.

When is the next Dermapharm earnings date?▼

Dermapharm is going to release the next earnings report on May 13, 2026.

What were Dermapharm earnings last quarter?▼

0A5J.LSE earnings for the last quarter are 0.7 EUR per share, whereas the estimation was 0.41 EUR resulting in a +68.29% surprise. The estimated earnings for the next quarter are N/A EUR per share.

What is Dermapharm revenue for the last year?▼

Dermapharm revenue for the last year amounts to 2.36B EUR.

What is Dermapharm net income for the last year?▼

0A5J.LSE net income for the last year is 227.57M EUR.

Does Dermapharm pay dividends?▼

Yes, 0A5J.LSE dividends are paid annual. The last dividend per share was 0.9 EUR. As of today, Dividend Yield (FWD)% is 1.93%.

How many employees does Dermapharm have?▼

As of April 25, 2026, the company has 3,610 employees.

In which sector is Dermapharm located?▼

Dermapharm operates in the Other sector.

When did Dermapharm complete a stock split?▼

Dermapharm has not had any recent stock splits.

Where is Dermapharm headquartered?▼

Dermapharm is headquartered in Grünwald, Germany.